IPDx Diagnostics OÜ

IPDx Diagnostics is a privately held company using immunoprofiling technology, MVA, to develop database of disease and heath condition specific immunoprofiles as well as novel laboratory and point of are diagnostic tests for several disease conditions, including endometriosis, autoimmune diseases and several others.

IPDx laboratories are set up for a broad spectrum of techniques for molecular biology and immunology analyses including automated phage display library screening, data analysis packages for big data analysis of immunoprofiles, production and analysis of peptide arrays for the analysis of antibodies. The company has developed a database of immunoprofiles of more than 3000 individuals and analysis tools for data mining.

Publication

Prostaglandin D2 receptor DP1 antibodies predict vaccine-induced spontaneous narcolepsy typ1: large scale study of antibody profiling. Sadam H, Pihlak A, Kivil A, Pihelgas S, Jaago M, Adler P, Vilo J, Vapalahti O, Neuman T, Lindholm D, Partinen M, Vaheri A, Palm K. EBioMedicine. 2018 Mar;29:47-59.